VMI
NXTC icon

VHCP Management III’s NextCure NXTC Stock Holding History

VHCP Management III’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$6.74M Buy
+9,974
New +$5M 1.34% 15

Other funds holding NXTC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VHCP Management III's NXTC Position: Q4 2019 in Review

VHCP Management III opened a new position in NextCure (NXTC) in Q4 2019: 9,974 shares worth $6.74M. The stake represents 1.34% of the portfolio and ranks #15 among its holdings.

88 funds tracked by Wall St. Rank hold NXTC as of Q4 2019.

  • VHCP Management III held 9,974 shares of NextCure worth $6.74M as of Q4 2019.
  • NextCure was a new VHCP Management III position in Q4 2019.
  • NextCure made up 1.34% of VHCP Management III's portfolio in Q4 2019, its #15 holding.
  • 88 funds tracked by Wall St. Rank held NextCure as of Q4 2019.

Based on VHCP Management III's 13F filing for Q4 2019, filed 13 Feb 2020.